PTOV1 anticorps (AA 61-160) (Biotin)

N° du produit ABIN1388665

Cet anticorps Lapin Polyclonal détecte spécifiquement PTOV1 dans WB, ELISA, IHC (p) et IHC (fro). Il présente une réactivité envers Humain, Souris et Rat.

Aperçu rapide pour PTOV1 anticorps (AA 61-160) (Biotin) (ABIN1388665)

Antigène: PTOV1 (Prostate Tumor Overexpressed 1 (PTOV1))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PTOV1 est conjugé à/à la Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Détail du produit anti-PTOV1 anticorps (Biotin)

Épitope: AA 61-160

Réactivité croisée: Humain, Souris, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human PTOV1

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur PTOV1

Antigène: PTOV1 (Prostate Tumor Overexpressed 1 (PTOV1))

Autre désignation: PTOV1

Sujet:

Synonyms: ACID2, Activator interaction domain containing protein 2, Gcap3, prostate tumor overexpressed 1, Prostate tumor overexpressed gene 1, PTOV 1, PTOV1_HUMAN, Prostate tumor-overexpressed gene 1 protein, PTOV-1, Activator interaction domain-containing protein 2.

Background: PTOV1 belongs to the Mediator complex subunit 25 family, PTOV1 subfamily. It may activate transcription and is required for nuclear translocation of FLOT1. PTOV1 promotes cell proliferation. There are three named isoforms.